<SEC-DOCUMENT>0000897069-21-000335.txt : 20210816
<SEC-HEADER>0000897069-21-000335.hdr.sgml : 20210816
<ACCEPTANCE-DATETIME>20210713171047
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000897069-21-000335
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210713

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DAXOR CORP
		CENTRAL INDEX KEY:			0000027367
		IRS NUMBER:				132682108
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		350 FIFTH AVENUE
		STREET 2:		SUITE 4740
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118
		BUSINESS PHONE:		212-330-8500

	MAIL ADDRESS:	
		STREET 1:		350 5TH AVENUE
		STREET 2:		SUITE 4740
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IDANT CORP
		DATE OF NAME CHANGE:	19730823
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Foley & Lardner LLP
         Document created using EDGARfilings PROfile 7.4.1.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="margin: 0px 0px 24pt; font-size: 12pt;">
      <table cellspacing="0" cellpadding="0" id="z5600f0a2b42b47168ab0d28606013191" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 69.43%; vertical-align: top;">
              <div style="text-align: justify;"><img width="141" height="53" src="image0.jpg"></div>
              <div>&#160;</div>
            </td>
            <td style="width: 30.57%; vertical-align: top;">
              <div style="font-size: 8pt; font-weight: bold;">ATTORNEYS AT LAW</div>
              <div style="font-size: 8pt;">777 EAST WISCONSIN AVENUE</div>
              <div style="font-size: 8pt;">MILWAUKEE, WI&#160; 53202-5306</div>
              <div style="font-size: 8pt;">414.271.2400 TEL</div>
              <div style="font-size: 8pt;">414.297.4900 FAX</div>
              <div style="font-size: 8pt;">WWW.FOLEY.COM</div>
              <div>&#160;</div>
              <div style="font-size: 8pt;">WRITER&#8217;S DIRECT LINE</div>
              <div>&#160;</div>
              <div style="font-size: 8pt;">CLIENT/MATTER NUMBER</div>
              <div style="font-size: 8pt;">103159-0101</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; margin-left: 234pt; margin-bottom: 24pt; font-size: 12pt;">July 13, 2021</div>
    <table cellspacing="0" cellpadding="0" id="z2fc5e313a291438395714b0f15fb2663" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; font-size: 12pt; font-weight: bold;"><u>VIA EDGAR SYSTEM</u></div>
            <div style="text-align: justify; font-size: 12pt;"> <br>
            </div>
            <div style="text-align: justify; font-size: 12pt;">Ms. Deborah L. O&#8217;Neal</div>
            <div style="text-align: justify; font-size: 12pt;">Ms. Christina DiAngelo Fettig</div>
            <div style="text-align: justify; font-size: 12pt;">U.S. Securities and Exchange Commission</div>
            <div style="text-align: justify; font-size: 12pt;">Division of Investment Management</div>
            <div style="text-align: justify; font-size: 12pt;">Washington, DC 20549</div>
            <div>&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z7e93b80a07f64c2d91c5895899b7b108" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 12pt;">

        <tr>
          <td style="width: 72pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-size: 12pt;">Re:</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 12pt;"><u>Daxor Corporation, File Nos. 333-255212 and 811-22684</u></div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-bottom: 12pt; font-size: 12pt;">Dear Ms. O&#8217;Neal and Ms. Fettig:</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-size: 12pt;">On behalf of our client, Daxor Corporation (&#8220;<u>Daxor</u>&#8221;), set forth below is Daxor&#8217;s response to the comments of the Staff (the &#8220;<u>Staff</u>&#8221;) of the Securities and Exchange Commission (the
      &#8220;<u>Commission</u>&#8221;), with respect to the above-referenced filing.&#160; The numbered items set forth below repeat (in bold italics) the oral comments of the Staff, and
      following the comments are Daxor&#8217;s responses (in regular type).&#160; In connection with this response letter, Daxor is filing a pre-effective amendment to the registration statement to reflect the comments on the registration statement, and will request
      effectiveness for the registration statement under separate cover.&#160; Attached to this response letter is a redlined copy of the registration statement showing the changes made in response to the Staff&#8217;s comments.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt; font-weight: bold; font-style: italic;">1.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-weight: bold; font-style: italic; font-size: 12pt;">Please explain how Daxor is qualified to elect to file a
        registration statement pursuant to General Instruction A.2 of Form N-2.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"><u>Response</u></font><font style="font-size: 12pt;">:</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 72pt">&#160;</font><font style="font-size: 12pt;">Daxor meets the requirements set forth in&#160;General Instruction
        A.2 as follows:</font></div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z1ef4c53f309146dfb91b6d90db24f53f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="margin-left: 54pt; margin-bottom: 12pt; font-size: 12pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 12pt; font-size: 12pt;">Daxor meets the requirements of General Instruction I.A. of Form S-3:</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zb68e7436817a4674aa55ea36dd0ff904" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; vertical-align: top; align: right;">
              <div style="margin-left: 90pt; margin-bottom: 12pt; font-size: 12pt;">o</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 12pt; font-size: 12pt;">Daxor is organized under the laws of the United States, New York, and has its principal business operations in the United
                States, in Tennessee and New York.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z2f8af935992a431894137edaf4941edf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; vertical-align: top; align: right;">
              <div style="margin-left: 90pt; margin-bottom: 12pt; font-size: 12pt;">o</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 12pt; font-size: 12pt;">Daxor has securities registered under Section 12(g), listed on the NYSE AMEX.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zc6f6b86f81aa4208be5e072c839cb9dd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; vertical-align: top; align: right;">
              <div style="margin-left: 90pt; margin-bottom: 12pt; font-size: 12pt;">o</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 12pt; font-size: 12pt;">Daxor (a) has been subject to the requirements of Section 12 of the Exchange Act for many years, and has filed the required
                materials; and (b) Daxor has timely filed all required public reports, as reflected on the EDGAR database.</div>
            </td>
          </tr>

      </table>
      <div>
        <table cellspacing="0" cellpadding="0" id="z80f97ce92cfd48a09ade431e9aea28d0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 19.99%; vertical-align: top;">
                <div style="font-size: 8pt;">AUSTIN</div>
                <div style="font-size: 8pt;">BOSTON</div>
                <div style="font-size: 8pt;">CHICAGO</div>
                <div style="font-size: 8pt;">DALLAS</div>
                <div style="font-size: 8pt;">DENVER</div>
              </td>
              <td style="width: 20%; vertical-align: top;">
                <div style="font-size: 8pt;">DETROIT</div>
                <div style="font-size: 8pt;">HOUSTON</div>
                <div style="font-size: 8pt;">JACKSONVILLE</div>
                <div style="font-size: 8pt;">LOS ANGELES</div>
                <div style="font-size: 8pt;">MADISON</div>
              </td>
              <td style="width: 19.99%; vertical-align: top;">
                <div style="font-size: 8pt;">MEXICO CITY</div>
                <div style="font-size: 8pt;">MIAMI</div>
                <div style="font-size: 8pt;">MILWAUKEE</div>
                <div style="font-size: 8pt;">NEW YORK</div>
                <div style="font-size: 8pt;">ORLANDO</div>
              </td>
              <td style="width: 20%; vertical-align: top;">
                <div style="font-size: 8pt;">SACRAMENTO</div>
                <div style="font-size: 8pt;">SAN DIEGO</div>
                <div style="font-size: 8pt;">SAN FRANCISCO</div>
                <div style="font-size: 8pt;">SILICON VALLEY</div>
                <div style="font-size: 8pt;">TALLAHASSEE</div>
              </td>
              <td style="width: 20%; vertical-align: top;">
                <div style="font-size: 8pt;">TAMPA</div>
                <div style="font-size: 8pt;">WASHINGTON, D.C.</div>
                <div style="font-size: 8pt;">BRUSSELS</div>
                <div style="font-size: 8pt;">TOKYO</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <div style="text-align: justify; margin-top: 8pt; margin-bottom: 12pt;"><img width="141" height="53" src="image0.jpg"></div>
        <div style="text-align: justify;">U.S. Securities and Exchange Commission</div>
        <div style="text-align: justify;">July 13, 2021</div>
        <div style="text-align: justify; margin-bottom: 12pt;">Page 2</div>
      </div>
      <div> <br>
      </div>
      <div> <br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z170e84c00280424e9ad37424e92aff3c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; vertical-align: top; align: right;">
              <div style="margin-left: 90pt; margin-bottom: 12pt; font-size: 12pt;">o</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 12pt; font-size: 12pt;">Daxor has not (a) failed to pay any dividend or sinking fund installment on preferred stock; or (b) defaulted (i) on any
                installment or installments on indebtedness for borrowed money, or (ii) on any rental on one or more long term leases, which defaults in the aggregate are material to the financial position of the registrant and its consolidated and
                unconsolidated subsidiaries, taken as a whole.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zed88728e67894c49afa9b99c03f42a35" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 108pt; vertical-align: top; align: right;">
              <div style="margin-left: 90pt; margin-bottom: 12pt; font-size: 12pt;">o</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 12pt; font-size: 12pt;">Daxor has (a) filed all required electronic filings; and (b) filed the required Interactive Data Files.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z9664a8322ea84c30b7e535d34d6fd4f3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="margin-left: 54pt; margin-bottom: 12pt; font-size: 12pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 12pt; font-size: 12pt;">Daxor has been registered under the Investment Company Act for many years, and has timely filed all public reports required
                to be filed pursuant to Section 30 of the Investment Company Act during the twelve calendar months and any portion of a month immediately preceding the filing of the registration statement, as reflected on the EDGAR database.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z558e14c2c66f46a59df9b40242d7ec96" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 72pt; vertical-align: top; align: right;">
              <div style="margin-left: 54pt; margin-bottom: 12pt; font-size: 12pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 12pt; font-size: 12pt;">Daxor&#8217;s registration statement relates to a limited primary offering, as provided in General Instruction I.B.6.&#160; In the
                registration statement, Daxor specifies that the aggregate market value of securities sold by or on behalf of Daxor during the period of 12 calendar months immediately prior to, and including, the sale is no more than one-third of the
                aggregate market value of the voting and non-voting common equity held by non-affiliates of Daxor.&#160; Daxor is not a shell company and has not been a shell company at any time previously, and Daxor has at least one class of common equity
                securities listed and registered on a national securities exchange (NYSE AMEX).</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt; font-weight: bold; font-style: italic;">2.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-weight: bold; font-style: italic; font-size: 12pt;">Please state that expenses are estimated in the Annual Expense
        table.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"><u>Response</u></font><font style="font-size: 12pt;">:</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 72pt">&#160;</font><font style="font-size: 12pt;">Daxor will revise the disclosure as requested.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt; font-weight: bold; font-style: italic;">3.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-weight: bold; font-style: italic; font-size: 12pt;">We note that Total Annual Expenses after Taxes are shown as
        4.84% in the Annual Expense table.&#160; The financial highlights show Total Annual Expenses after Taxes of 5.79%.&#160; Please explain the difference.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"><u>Response</u></font><font style="font-size: 12pt;">:</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 72pt">&#160;</font><font style="font-size: 12pt;">The amount in the financial highlights was calculated using the &#8220;average net assets&#8221; based on the value of net assets determined no less
          frequently than the end of each month.&#160; In the Form N-2, the amount is based on the net assets at December 31, 2020, as Daxor thought that was the amount that
          should be used.&#160; Daxor will revise the disclosure to use the amount found in the financial highlights.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"> <br>
        </font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="margin: 0px 0px 12pt; text-align: justify;"><img width="141" height="53" src="image0.jpg">
      <div>U.S. Securities and Exchange Commission</div>
      <div>July 13, 2021</div>
      <div style="margin-bottom: 12pt;">Page 3<br>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt; font-weight: bold; font-style: italic;">4.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-weight: bold; font-style: italic; font-size: 12pt;">We note that the Example numbers need to be redone to be based
        on a $1,000 investment, assuming a 5% annual return.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"><u>Response</u></font><font style="font-size: 12pt;">:</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 72pt">&#160;</font><font style="font-size: 12pt;">Daxor will revise the disclosure as requested.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt; font-weight: bold; font-style: italic;">5.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-weight: bold; font-style: italic; font-size: 12pt;">On the financial highlights: (a) ensure the nature of the
        information contained in the table and its source is explained, and note that the auditor&#8217;s report is contained elsewhere in the registration statement, and state that it can be obtained by shareholders; (b) ensure information in comparative
        columns for each of the last ten fiscal years, and present the information for the period between the end of the latest fiscal year and the date of the latest balance sheet or statement of assets and liabilities; and (c) state that the financial
        highlights are audited.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"><u>Response</u></font><font style="font-size: 12pt;">:</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 72pt">&#160;</font><font style="font-size: 12pt;">Daxor will revised the disclosure as requested.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt; font-weight: bold; font-style: italic;">6.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-weight: bold; font-style: italic; font-size: 12pt;">Please provide an explanation of how Daxor will comply with the
        new derivatives rule.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"><u>Response</u></font><font style="font-size: 12pt;">:</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 72pt">&#160;</font><font style="font-size: 12pt;">Under new Rule 18f-4, Daxor intends to qualify as a &#8220;limited derivatives user&#8221; by limiting its derivatives exposure to 10% of its net assets, and as such will be exempted from the derivatives risk management program
          requirement and the &#8220;Value-at-Risk-based&#8221; limit on fund leverage risk.&#160; Daxor will adopt and implement written policies and procedures reasonably designed to
          manage Daxor&#8217;s derivatives risks.&#160; With regard to margin loans, Daxor will continue to treat margin loans as &#8220;senior securities&#8221; and comply with the asset coverage requirements.&#160; Release No. IC-34084, &#8220;Use of Derivatives by Registered
        Investment Companies and Business Development Companies,&#8221; at footnote 728, provides that a &#8220;similar financing transaction&#8221; under the new rule includes a &#8220;fund&#8217;s purchase of a security on margin.&#8221;&#160; Rule 18f-4(d) provides, with regard to a similar
        financing transaction (the margin loan in this case), that Daxor may (a) &#8220;comply with the asset coverage requirements of Section 18, and combine the aggregate amount of
          indebtedness associated with all reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing indebtedness when calculating the asset coverage ratio;&#8221; or (b) &#8220;treat all
          reverse repurchase agreements or similar financing transactions as derivatives transactions for all purposes under&#8221; Section 18.&#160; Daxor could elect to treat the margin loans as derivative transactions for all purposes of the new rule,
        which would be advantageous if the Fund is already subject to the Value-at-Risk limitations.&#160; However, as the Fund is a limited derivatives user not subject to Value-at-Risk limitations, it should be more beneficial to treat the margin loans as
        senior securities.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"> <br>
      </font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="margin: 0px 0px 12pt;"><img width="141" height="53" src="image0.jpg">
      <div style="text-align: justify;">U.S. Securities and Exchange Commission</div>
      <div style="text-align: justify;">July 13, 2021</div>
      <div style="text-align: justify; margin-bottom: 12pt;">Page 4</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt; font-weight: bold; font-style: italic;">7.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-weight: bold; font-style: italic; font-size: 12pt;">There is disclosure that Daxor receives significant income from
        options sales.&#160; Was this true in the most recent fiscal year?&#160; Prior year?</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"><u>Response</u></font><font style="font-size: 12pt;">:</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 72pt">&#160;</font><font style="font-size: 12pt;">This was not true in the most recent fiscal year, or the prior
        year, and Daxor will remove that disclosure.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt; font-weight: bold; font-style: italic;">8.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-weight: bold; font-style: italic; font-size: 12pt;">Ensure that the high and low sales prices for the stock for
        each full quarterly period within the two most recent fiscal years and each full fiscal quarter since the beginning of the current fiscal year are reported.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"><u>Response</u></font><font style="font-size: 12pt;">:</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 72pt">&#160;</font><font style="font-size: 12pt;">Daxor will revise the disclosure as requested.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt; font-weight: bold; font-style: italic;">9.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt; font-weight: bold; font-style: italic;">Please update Footnote 6 to the Fee Table.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"><u>Response</u></font><font style="font-size: 12pt;">:</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 72pt">&#160;</font><font style="font-size: 12pt;">Daxor will revise the disclosure as requested.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt; font-weight: bold; font-style: italic;">10.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt; font-weight: bold; font-style: italic;">With regard to the &#8220;Put and Call Options Risk,&#8221; disclosure,
        please consider expanding this risk disclosure.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"><u>Response</u></font><font style="font-size: 12pt;">:</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 72pt">&#160;</font><font style="font-size: 12pt;">Daxor will revise the disclosure as requested.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt; font-weight: bold; font-style: italic;">11.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt; font-weight: bold; font-style: italic;">Please confirm that no sales have been made under the
        registration statement, and that none will be made until it is declared effective.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"><u>Response</u></font><font style="font-size: 12pt;">:</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 72pt">&#160;</font><font style="font-size: 12pt;">Daxor confirms that no sales have been made under the
        registration statement, and that none will be made until it is declared effective.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt; font-weight: bold; font-style: italic;">12.</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><font style="font-size: 12pt; font-weight: bold; font-style: italic;">Please ensure each filing is accompanied by a transmittal
        letter that explains the filing, the reason for the filing, and appropriate contact information.</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt;"><font style="font-size: 12pt;"><u>Response</u></font><font style="font-size: 12pt;">:</font><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 72pt">&#160;</font><font style="font-size: 12pt;">With regard to future filings, Daxor will ensure that an appropriate transmittal letter is filed.</font></div>
    <div style="text-align: center; margin-bottom: 12pt; font-size: 12pt;">* * * * *</div>
    <div style="text-align: center; margin-bottom: 12pt; font-size: 12pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="margin: 0px 0px 12pt; font-size: 12pt;">
      <div style="text-align: justify; margin-top: 8pt; margin-bottom: 12pt;"><img width="141" height="53" src="image0.jpg"></div>
      <div style="text-align: justify; font-size: 10pt;">U.S. Securities and Exchange Commission</div>
      <div style="text-align: justify; font-size: 10pt;">July 13, 2021</div>
      <div style="text-align: justify; margin-bottom: 12pt; font-size: 10pt;">Page 5<br>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 72pt; margin-bottom: 12pt; font-size: 12pt;">If the Staff has any questions with respect to any of the foregoing, please contact the undersigned at (414)
      297-5596.</div>
    <div style="text-align: justify; text-indent: 216pt; font-size: 12pt;">Very truly yours,</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 216pt; font-size: 12pt;">/s/ Peter D. Fetzer</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 216pt; font-size: 12pt;">Peter D. Fetzer</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; font-size: 12pt;">Enclosures</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-size: 12pt;">cc:&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 12pt;">Michael Feldschuh (w/o enclosures)</font></div>
    <div style="text-align: justify; text-indent: 36pt; font-size: 12pt;">Robert Michel (w/o enclosures)</div>
    <div style="text-align: justify; text-indent: 36pt; font-size: 12pt; font-style: italic;">Daxor Corporation</div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "I ;T# 2(  A$! Q$!_\0
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M+MU-C$]M'$1$!_K/D )#D\ CH@(R&KYL^'_@ZX\<>+;;28OEMU_?7D@<*8X
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MY_W_ (?_ (U5S2?@'X5T;6;'5+?4-9:>RN([B-9)HBI9&# '$8.,CU%>J44
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M .C9:\?H U/#6FPZSXJTC2[AI%@O;V&WD:,@,%=PI(R",X/H:^B_^&<?!_\
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M "F__;: /G^O8/V<?^2AZA_V"I/_ $;%70?\,R_]3=_Y3?\ [;77_#CX/_\
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M2M__ (W0!]?T5\@?\+M^(?\ T,/_ ))6_P#\;H_X7;\0_P#H8?\ R2M__C=
M'U_17R!_PNWXA_\ 0P_^25O_ /&Z^I_"=]<:GX-T._O)/,NKK3X)IGV@;G:-
M2QP.!DD]* -BBBB@ KY0^.GA'_A'/'+:E;KBQUG=<IS]V8$>:O+$GDA\X _>
M8'W:^KZYOQYX4A\9^#K_ $9Q&)Y$WVLCX_=S+RAS@D#/RD@9VLP'6@#XDKU#
MX%^+O^$<\<KIMPV+'6=ML_'W9@3Y3<*2>24QD#]YD_=KS.>":UN);>XBDAGB
M<I)'(I5D8'!!!Y!![5'0!]M^//%</@SP=?ZRYC,\:;+6-\?O)FX08R"1GYB
M<[58CI7Q1//-=7$MQ<2R33RN7DDD8LSL3DDD\DD]Z[CQ_P#$R^\=:7H5G.)(
MQ96^;O)P)[GE3)@87&T @;05+N.1@UP= !7V?\,O"/\ PA?@:RTV5=M]+_I-
M[SG]\X&5^\1\H"ID'!VY[UXA\ ?!O]L^*)/$-Y#NL=*_U.]<K)<$?+C*D'8,
MMP058QFOI^@ HHHH **^6/%GQ?\ '>F>,M<L+/7?+M;74)X84^R0':BR,%&2
MF3@ =:Q_^%V_$/\ Z&'_ ,DK?_XW0!]?T5\@?\+M^(?_ $,/_DE;_P#QNC_A
M=OQ#_P"AA_\ )*W_ /C= 'U_17R!_P +M^(?_0P_^25O_P#&Z](^"GQ$\5>+
M?&5Y8:YJGVNUCT]YE3[/%'AQ)& <HH/1C^= 'N]%%% 'R!\;?^2O:[_V[_\
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M ,E#U#_L%2?^C8J /I^BBB@#Y ^-O_)7M=_[=_\ T1'7G]>@?&W_ )*]KO\
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M /F"BBB@#[_HHHH **** "BBB@#Y@_:._P"2AZ?_ -@J/_T;+7C]>P?M'?\
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M_P!N_P#Z(CKS^@#T#X)?\E>T+_MX_P#1$E?7]?('P2_Y*]H7_;Q_Z(DKZ_H
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M_P"C9:\?KV#]H[_DH>G_ /8*C_\ 1LM>/T 7-)U*;1M9L=4MUC:>RN([B-9
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M8N",9XQW'/'/J^@>#O#GA9%71='M+1PA3SE3=*REMQ#2-EV&<<$GH/05N44
M%%%% !7'_$?P+_PL#P];Z3_:/V#R;M;GS?(\W.$==N-R_P!_.<]J["B@#P#_
M (9E_P"IN_\ *;_]MH_X9E_ZF[_RF_\ VVO?Z* / /\ AF7_ *F[_P IO_VV
MC_AF7_J;O_*;_P#;:]_HH \ _P"&9?\ J;O_ "F__;:/^&9?^IN_\IO_ -MK
MW^B@#P#_ (9E_P"IN_\ *;_]MKW^BB@#R_XC_!__ (6!XAM]6_MW[!Y-HMMY
M7V3S<X=VW9WK_?QC':N0_P"&9?\ J;O_ "F__;:]_HH \ _X9E_ZF[_RF_\
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M!8LQZ!54$L>IP > 3T!H U**Y/0/B7X/\4:HNF:/K4<]XR%UB:&2(N!UV[U
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M > ?%/\ Y.%\%?\ ;C_Z5O7O]> ?%/\ Y.%\%?\ ;C_Z5O7O] !7+_$;6?[
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MN-+T34KZ!=,C1I+6U>50WFRG!*@C."./<5]%T4 ?,'_"9?'/_GUUS_P0K_\
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(H **** /_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
